2nd meeting on novel adjuvants currently in/close to human clinical testing-Reference-Cited by-同舟云学术

2nd meeting on novel adjuvants currently in/close to human clinical testing

Published:2002-05 Issue:17-18 Volume:20 Page:2155-2163
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kenney Richard T.,Regina Rabinovich N.,Pichyangkul Sathit,Price Virginia L.,Engers Howard D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. Novel adjuvants currently in clinical testing 2–4 November 1998, Foundation Merieux, Annecy, France: a meeting sponsored by the World Health Organization;Aguado;Vaccine,1999

2. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria;Perera;Infect. Immun.,1998

3. A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant;Heineman;Vaccine,1999

4. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines;Baldridge;Methods,1999

5. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations;Newman;Vaccine,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quillaja Saponin Characteristics and Functional Properties;Annual Review of Food Science and Technology;2019-03-25

2. An approach to local immunotoxicity induced by adjuvanted vaccines;International Immunopharmacology;2013-11

3. Adjuvants and Subunit Vaccines;Topley & Wilson's Microbiology and Microbial Infections;2010-03-15

4. Adjuvants in tuberculosis vaccine development;FEMS Immunology & Medical Microbiology;2010-02

5. Vaccine Adjuvants;Vaccines for Biodefense and Emerging and Neglected Diseases;2009